Does POMALIDOMIDE Cause Therapy non-responder? 209 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 209 reports of Therapy non-responder have been filed in association with POMALIDOMIDE (Pomalyst). This represents 0.2% of all adverse event reports for POMALIDOMIDE.
209
Reports of Therapy non-responder with POMALIDOMIDE
0.2%
of all POMALIDOMIDE reports
46
Deaths
20
Hospitalizations
How Dangerous Is Therapy non-responder From POMALIDOMIDE?
Of the 209 reports, 46 (22.0%) resulted in death, 20 (9.6%) required hospitalization, and 5 (2.4%) were considered life-threatening.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for POMALIDOMIDE. However, 209 reports have been filed with the FAERS database.
What Other Side Effects Does POMALIDOMIDE Cause?
Plasma cell myeloma (7,023)
Death (6,795)
Fatigue (6,530)
Pneumonia (5,792)
Off label use (3,845)
Diarrhoea (3,351)
White blood cell count decreased (3,328)
Neutropenia (3,029)
Rash (2,715)
Dyspnoea (2,543)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which POMALIDOMIDE Alternatives Have Lower Therapy non-responder Risk?
POMALIDOMIDE vs POMALYST
POMALIDOMIDE vs PONATINIB
POMALIDOMIDE vs PONATINIB\PONATINIB
POMALIDOMIDE vs PONESIMOD
POMALIDOMIDE vs PORACTANT ALFA